Email updates

Keep up to date with the latest news and content from Malaria Journal and BioMed Central.

Open Access Highly Accessed Methodology

A new method for detection of pfmdr1 mutations in Plasmodium falciparum DNA using real-time PCR

Anne Purfield1, Amy Nelson2, Anita Laoboonchai3, Kanungnij Congpuong4, Phillip McDaniel5, R Scott Miller3, Kathy Welch5, Chansuda Wongsrichanalai36 and Steven R Meshnick12*

Author Affiliations

1 Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, U.S.A

2 Department of Epidemiology, University of North Carolina School of Public Health, Chapel Hill, NC, U.S.A

3 Department of Immunology, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand

4 Bureau of Vector Diseases, Department of Disease Control, Ministry of Public Health, Thailand

5 Kwai River Christian Hospital, Sangkhlaburi, Kanchanaburi, Thailand

6 U.S. Naval Medical Research Unit, Jakarta, Indonesia

For all author emails, please log on.

Malaria Journal 2004, 3:9  doi:10.1186/1475-2875-3-9


The electronic version of this article is the complete one and can be found online at: http://www.malariajournal.com/content/3/1/9


Received:6 February 2004
Accepted:7 May 2004
Published:7 May 2004

© 2004 Purfield et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

Abstract

Background

Surveillance for drug-resistant Plasmodium falciparum should be a component of malaria control programmes. Real-time PCR methods for the detection of parasite single-nucleotide polymorphisms (SNPs) and gene amplification could be useful survellance tools.

Methods

A real-time PCR assay has been developed that identifies single nucleotide polymorphisms (SNPs) at amino acids 86, 184, 1034 and 1042 in the P. falciparum multi-drug resistant (pfmdr 1) gene that may be associated with anti-malarial drug resistance.

Results

This assay has a sensitivity and specificity of 94% and 100% when compared to traditional PCR methods for genotyping. Only 54 of 68 (79%) paired pre- and post-culture DNA samples were concordant at all four loci.

Conclusion

Real-time PCR is a sensitive and specific method to detect SNP's in pfmdr 1. Genotypes of parasites after in vitro culture may not reflect that seen in vivo.

Background

The increasing prevalence of multi-drug resistant parasites threatens to impede efforts to control malaria world-wide [1]. Current in vitro and in vivo methods to monitor the emergence of drug resistance are difficult, costly and labor-intensive. Molecular methods could prove to be useful alternatives [2].

For Plasmodium falciparum, the pfmdr 1 gene product, PGH1, is thought to play an integral role in the mechanism behind parasite resistance to multiple malarial drugs [3]. Both increased gene copy number and single-nucleotide polymorphisms (SNP's) have been associated in epidemiological studies with changes in sensitivity to chloroquine and mefloquine (reviewed in [1,4,5]). In two studies from South-east Asia, both increased pfmdr 1 gene copy number and SNPs have been associated with in vitro resistance to mefloquine [6,7].

In this manuscript, a real-time PCR assay has been developed for the detection of pfmdr 1 SNPs. This assay was developed to be used in conjunction with a previously developed assay for pfmdr 1 gene copy number [6] to assess molecular markers as predictors of mefloquine failure in a clinical study that took place in Sangkhlaburi, Thailand, in 2001–2. The results of the clinical study will be described in a subsequent publication.

Numerous studies have shown discrepancies between in vitro and in vivo tests for antimalarial drug resistance [8-11]. In order to understand why, pfmdr 1 genotypes were determined directly from patient blood and from cultures derived from those patients and compared.

Methods

Patient samples

Subject recruitment. This study received ethical approval from the University of North Carolina IRB and the Thai Ministry of Public Health. Patients presenting with slide-confirmed falciparum malaria to the free Ministry of Public Health malaria clinic or the Kwai River Christian Hospital clinic in Sangklaburi, Thailand from during July 2001 – August 2002 were enrolled. Patients with vivax infections, history of anti-malarial drug use within the past two weeks, bleeding tendency (by self-reported history or based on medical records), or severe/complicated malaria requiring prompt medical management for life support were excluded. In total, 74 patients consented. Blood samples were taken, aliquoted, stored in liquid nitrogen, and transported to the Armed Forces Research Institute for the Medical Sciences (AFRIMS) in Bangkok. At AFRIMS, aliquots were thawed for in vitro culture. 59 of the 74 patient blood samples were successfully cultured as previously described [6,12]. Parasites were cultured for between 2 and 188 days (mean = 38.5; median = 23). DNA was extracted from patient blood ("pre-culture") and cultured parasites ("post-culture") using the QiaAmp DNA Blood Minikit Blood and Body Fluid Spin Protocol (Qiagen, Valencia, CA) and then shipped on dry ice to the University of North Carolina.

Standard PCR

DNA was PCR-amplified using a MJ Thermocycler (MJ Research, Waltham, MA) as previously described [6]. DNA sequencing was performed at the University of North Carolina Sequencing Core facility using a 3100 Genetic Analyser (Applied Biosystems, Foster City, CA). The sequencing reaction was done using the ABI PRISM™ BigDye™ Terminator Cycle Sequencing Ready Reaction Kit with AmpliTaq® DNA Polymerase, FS (Applied Biosystems).

Real-time PCR

For real-time PCR, pre-culture DNA and post-culture DNA were genotyped using an Applied Biosystems Prism 7000 Sequence Detection System (Applied Biosystems). This assay uses sequence-specific fluorescently-labelled "MGB™ " probes to distinguish SNPs [13-15]. Primers and probes (Table 1) were designed using Primer Express Software, Version 2.0 (Applied Biosystems). Primers were obtained from Qiagen. Fluorescent MGB™ probes were produced by Applied Biosystems and labelled with reporter dyes, 6FAM or VIC, at their 5' ends and non-fluorescent quencher molecules at their 3' ends. Primer and probe concentrations were optimized according to the TaqMan Universal PCR Master Mix technical bulletin (Applied Biosystems) using DNA obtained from P. falciparum strain 3D7 or from patient specimens. 300 nM of both forward and reverse primers were found to be optimal for all SNPs. Optimal probe concentration was determined to be 250 nM for all MGB probes used in this study. Using 10-fold serial dilutions of 3D7 genomic P. falciparum DNA, as few as 8 copies (0.001 ng) of genomic P. falciparum DNA could be detected.

Table 1. Primers and probes used in real-time PCR assay

Each real-time PCR amplification reaction contained both the wild type probe labelled with FAM, and the mutant probe labelled with VIC. Presence of either SNP could be imputed from the relative increase of fluorescence of the two fluorophores (Fig. 1). All reactions were done in duplicate.

thumbnailFigure 1. Fluorescent intensity (Rn) of the FAM reporter dye (blue line) compared to VIC reporter dye (green line) as PCR amplification cycles proceed (x axes). Fluorescent intensity is measured as Rn (y-axes), the absolute fluorescence of the reporter dye divided by that of the passive reference dye, Rox. An increase in FAM indicates a wild type population [86(e), 184(f), 1034(g), 1042(h)] while an increase in VIC indicates a mutant population [86(a), 184(b), 1034(c), 1042(d)]. Polyclonal infections may be identified by an increase in fluorescent intensity of both reporter dyes (not shown). Mutant 1034 DNA (c) was obtained from a previous study [6] because none of the samples in this study contained that mutation.

Results

Parasite culture

Of the 74 patients enrolled, parasites were successfully cultured from 59. Following treatment, 20 of the 74 admission patients recrudesced. Parasites were successfully cultured from 13 of these 20 recrudescent patients.

Sensitivity and Ssecificity of Real-Time PCR

The sensitivity and specificity of SNP detection using real-time PCR were measured in 22 post-culture DNA samples using DNA sequencing as the gold standard (Table 2). Nineteen cultures were derived from blood of patients upon admission to the study. The other three cultures were obtained from who failed treatment. Two samples contained mixtures of SNPs at single positions based on DNA sequencing. Of the 20 monoclonal samples, 19 were concordant for all pfmdr 1 SNPs when analysed using both methods. The discordant sample was not an artefact since both the real-time PCR and sequencing reactions gave identical results when repeated. The discordant sample contained a single discrepancy at position 184 (phenylalanine by sequencing and tyrosine by real-time PCR). Thus, the sensitivity of real-time PCR method to detect Tyr86 or Asp1042 SNPs was 100% and the sensitivity to detect Phel84 was 92%; there were no Cysl034 mutations detected. Real-time PCR was 100% specific for each mutation. The sensitivity and specificity of the assay to detect all four SNPs were 94% and 100%, respectively.

Table 2. Prevalence in monoclonal culture samples (n = 20) of mutations detected by traditional PCR and sequencing (gold standard) and real-time PCR, and sensitivity and specificity of realtime PCR assay.

Two of the 22 samples were found to be mixed infections when sequenced. One sample contained a mixture of Tyrl84 and Phel84. The other sample contained a mixture of Asn86 and His86. The real-time PCR method accurately identified the Tyrl84/Phel84 mixed population. However, because the probes were designed to detect only Asn86 or Tyr86, His86 was not detected by real-time PCR.

Comparison of SNPs pre- and post-culture

In order to determine how the process of culturing parasites in vitro alters genotype, a comparison was made between the pfmdr 1 genotypes of DNA extracted from pre-and post-culture parasites as measured by real-time PCR. Of the paired pre- and post-culture specimens, both members of 68 pairs were successfully amplified by real-time PCR. Fifty-eight of these pairs were obtained from admission patient blood while 10 pairs were derived from recrudescent patients.

Fifty-eight of the pre-culture genotypes were monoclonal, nine pre-culture samples had mixtures of alleles at single positions, and one had mixed SNPs at two positions (184 and 1042). Table 3 shows the number of isolates with specific combinations of pfmdr 1 genotypes pre- and post-culture at each specific locus. Isolates with identical genotype at each locus before and after culture are enumerated in the shaded diagonal. Overall, fifty-four of 68 (79%) pre-culture DNA samples were completely concordant with post-culture DNA at all four polymorphic sites examined. While there was a wide variation in the length of time parasites were cultured before DNA was extracted, there was no correlation between genotype discordances and length of time in culture (data not shown). Five of the 14 discordant isolates exhibited single differences at position 184, and two were different at position 1042. Seven discrepant samples contained mixtures of alleles at one or more sites before and/or after culture. Six samples showed a mixture of alleles pre-culture and single alleles post-culture. This type of selection occurred at amino acid 184 for four isolates, and 1042 for two isolates. Two of these six also had changes at a second position, amino acid 86. Finally, one of the seven samples was monoclonal at aminoacid 184 pre-culture but polyclonal post-culture (and also exhibited a change from Asn to Asp at 1042).

Table 3. Genotype results of DNA from pre-culture and post-culture DNA by real-time PCR

Novel His86 mutation identified

In one DNA culture sample neither wild type nor mutant probes revealed amplification during real-time PCR. This post-culture sample was amplified by standard PCR methods and sequenced to genotype the position 86 region. Sequencing this sample revealed a His86.

Discussion

In this paper, a real-time PCR method is described which accurately ascertains parasite pfmdr 1 genotype. This method has high sensitivity (94%) and specificity (100%) for detecting four pfmdr 1 SNPs associated with drug resistance. There was a 21% discordance in the real-time PCR genotype results between DNA samples obtained directly from patient blood and DNA samples obtained from subsequent in vitro cultures.

Real-time PCR offers several advantages over standard PCR methods for genotyping DNA. First, because of the small volume the material, costs for real-time PCR are much lower than for standard PCR and are as little as $0.40 per reaction. Second, using real-time PCR, a single technician can perform and analyse hundreds of reactions per day, thus reducing the labor cost as well. Third, this method reduces the opportunity for post-PCR contamination. Once the sample is prepared with the reagents, amplification and analysis are completed in a closed-tube system. Finally, real-time PCR analysis of genotype is easier and requires less scientific expertise for analysis. Thus, the initial cost of a real-time PCR instrument (~$40,000) would be offset by savings in labor, quality assurance, and materials in labs analysing large numbers of samples.

In this paper, a novel His86 mutation was identified in two samples. To our knowledge, this mutation has never been identified before and may or may not be associated with drug resistance. Further studies on this mutation are needed.

A previous study utilized a novel real-time PCR technology to identify pfmdr 1 SNPs in parasite DNA extracted from clinical blood samples [16]. Although the chemistry of the assay differed from the technique described here, both studies yielded similar results and concluded that real-time PCR may accurately detect Asn86 → Tyr86, Tyr184 → Phe184, Ser1034 → Cys1034 and Asn1042 → Asp1042 in pfmdr 1. In addition, de Monbrison, et al., used this method to genotype Asp1246 → Tyr1246. SNPs at 1246 were not studied here because they have not been found in South-east Asia [6,7].

Twenty-one percent of samples manifested differences in pfmdr 1 genotype pre- and post-culture. Since most patients are probably infected with a mixture of strains, the genotypes observed post-culture reflects the results of the selection of a subset of strains by in vitro culture conditions. This could manifest itself as loss of strains observed pre-culture or the appearance of strains not observed pre-culture because they were present at levels below detection limits. A much greater change in genotype (74.5%) was observed in a previous study looking at variations in the polymorphic regions of MSP1 and MSP2 (merozoite surface protein 1 and 2) as well as GLURP (glutamate-rich protein) [17], perhaps because these genes are more variable.

In addition to SNP detection, our group has previously described a real-time PCR method to measure pfmdr 1 gene amplification [6]. Thus it is now possible to assess both pfmdr 1 gene copy number and SNPs using real-time PCR making it possible to carry out a complete assessment of pfmdr 1 genetics in large cohorts.

Conclusions

Real-time PCR is a sensitive and specific method to detect pfmdr 1 mutations and gene amplification. Because it is inexpensive and amenable to high-throughput, it could be a useful public health tool.

Acknowledgements

This work was supported by NIH grant R23 AI054590 and US Department of Defense-Global Emerging Infections Surveillance and Response Program (DoD-GEIS). We would like to acknowledge AFRIMS Malaria Field Team, Mark Fukuda, Paul Wilson, Charlotte Lanteri, Jesse Kwiek, Alisa Alker, the staff of Kwai River Christian Hospital and of the Vector Borne Diseases Control Unit #9 (Sangkhlaburi) for their assistance and support.

References

  1. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR: Epidemiology of drug-resistant malaria.

    Lancet Infect Dis 2002, 2:209-218. PubMed Abstract | Publisher Full Text OpenURL

  2. Plowe CV: Monitoring antimalarial drug resistance: making the most of the tools at hand.

    J Exp Biol 2003, 206:3745-3752. PubMed Abstract | Publisher Full Text OpenURL

  3. Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF: Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum.

    Nature 2000, 403:906-909. PubMed Abstract | Publisher Full Text OpenURL

  4. Wernsdorfer WH, Noedl H: Molecular markers for drug resistance in malaria: use in treatment, diagnosis and epidemiology.

    Curr Opin Infect Dis 2003, 16:553-558. PubMed Abstract | Publisher Full Text OpenURL

  5. Talisuna AO, Bloland P, D'Alessandro U: History, dynamics, and public health importance of malaria parasite resistance.

    Clin Microbiol Rev 2004, 17:235-254. PubMed Abstract | Publisher Full Text OpenURL

  6. Pickard AL, Wongsrichanalai C, Purfield A, Kamwendo D, Emery K, Zalewski C, Kawamoto F, Miller RS, Meshnick SR: Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1.

    Antimicrob Agents Chemother 2003, 47:2418-2423. PubMed Abstract | Publisher Full Text OpenURL

  7. Price RN, Cassar C, Brockman A, Duraisingh M, van Vugt M, White NJ, Nosten F, Krishna S: The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand.

    Antimicrob Agents Chemother 1999, 43:2943-2949. PubMed Abstract | Publisher Full Text OpenURL

  8. Takechi M, Matsuo M, Ziba C, MacHeso A, Butao D, Zungu IL, Chakanika I, Bustos MD: Therapeutic efficacy of sulphadoxine/pyrimethamine and susceptibility in vitro of Plasmodium falciparum isolates to sulphadoxine-pyremethamine and other antimalarial drugs in Malawian children.

    Trop Med Int Health 2001, 6:429-434. PubMed Abstract | Publisher Full Text OpenURL

  9. Ringwald P, Basco LK: Comparison of in vivo and in vitro tests of resistance in patients treated with chloroquine in Yaounde, Cameroon.

    Bull World Health Organ 1999, 77:34-43. PubMed Abstract OpenURL

  10. Segurado AA, di Santi SM, Shiroma M: In vivo and in vitro Plasmodium falciparum resistance to chloroquine, amodiaquine and quinine in the Brazilian Amazon.

    Rev Inst Med Trop Sao Paulo 1997, 39:85-90. PubMed Abstract OpenURL

  11. Dua VK, Kar PK, Gupta NC, Kar I, Sharma VP: In vivo and in vitro sensitivity of Plasmodium falciparum to chloroquine in Chennai (Tamil Nadu), India.

    Indian J Malariol 1997, 34:1-7. PubMed Abstract OpenURL

  12. Trager W, Jensen JB: Human malaria parasites in continuous culture.

    Science 1976, 193:673-675. PubMed Abstract OpenURL

  13. Livak KJ: Allelic discrimination using fluorogenic probes and the 5' nuclease assay.

    Genet Anal 1999, 14:143-149. PubMed Abstract | Publisher Full Text OpenURL

  14. Afonina I, Zivarts M, Kutyavin I, Lukhtanov E, Gamper H, Meyer RB: Efficient priming of PCR with short oligonucleotides conjugated to a minor groove binder.

    Nucleic Acids Res 1997, 25:2657-2660. PubMed Abstract | Publisher Full Text OpenURL

  15. Holland PM, Abramson RD, Watson R, Gelfand DH: Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase.

    Proc Natl Acad Sci U S A 1991, 88:7276-7280. PubMed Abstract | Publisher Full Text OpenURL

  16. de Monbrison F, Raynaud D, Latour-Fondanaiche C, Staal A, Favre S, Kaiser K, Peyron F, Picot S: Real-time PCR for chloroquine sensitivity assay and for pfmdr1-pfcrt single nucleotide polymorphisms in Plasmodium falciparum.

    J Microbiol Methods 2003, 54:391-401. PubMed Abstract | Publisher Full Text OpenURL

  17. Viriyakosol S, Siripoon N, Zhu XP, Jarra W, Seugorn A, Brown KN, Snounou G: Plasmodium falciparum: selective growth of subpopulations from field samples following in vitro culture, as detected by the polymerase chain reaction.

    Exp Parasitol 1994, 79:517-525. PubMed Abstract | Publisher Full Text OpenURL